291 related articles for article (PubMed ID: 31788713)
1. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
[TBL] [Abstract][Full Text] [Related]
3. EFFICACY OF INTRAVITREAL RANIBIZUMAB INJECTIONS IN THE TREATMENT OF VITREOUS HEMORRHAGE RELATED TO PROLIFERATIVE DIABETIC RETINOPATHY.
Chelala E; Nehme J; El Rami H; Aoun R; Dirani A; Fadlallah A; Jalkh A
Retina; 2018 Jun; 38(6):1127-1133. PubMed ID: 28489694
[TBL] [Abstract][Full Text] [Related]
4. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
5. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
6. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
Yeh PT; Yang CH; Yang CM
Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double-masked, placebo-controlled feasibility study.
Petrarca R; Soare C; Wong R; Desai R; Neffendorf J; Simpson A; Jackson TL
Acta Ophthalmol; 2020 Dec; 98(8):e960-e967. PubMed ID: 31674134
[TBL] [Abstract][Full Text] [Related]
10. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
Nadal J; Carreras E; Canut MI
Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
[TBL] [Abstract][Full Text] [Related]
11. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (Observational Study).
Liang X; Zhang Y; Wang JX; Wang LF; Huang WR; Tang X
Medicine (Baltimore); 2019 May; 98(20):e15735. PubMed ID: 31096535
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ
Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
Hu L; Chen Q; Du Z; Wang W; Zhao G
Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
[TBL] [Abstract][Full Text] [Related]
15. A randomized study comparing the efficacy of bevacizumab and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy.
Pakzad-Vaezi K; Albiani DA; Kirker AW; Merkur AB; Kertes PJ; Eng KT; Fallah N; Forooghian F
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):521-4. PubMed ID: 25423631
[TBL] [Abstract][Full Text] [Related]
16. Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial.
Aleman I; Castillo Velazquez J; Rush SW; Rush RB
Br J Ophthalmol; 2019 Dec; 103(12):1740-1746. PubMed ID: 30705040
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Ferenchak K; Duval R; Cohen JA; MacCumber MW
Retina; 2014 Jun; 34(6):1177-81. PubMed ID: 24457977
[TBL] [Abstract][Full Text] [Related]
19. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
Gupta A; Bansal R; Gupta V; Dogra MR
Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.
Parikh RN; Traband A; Kolomeyer AM; VanderBeek BL; Kim BJ; Maguire AM; Brucker AJ
Am J Ophthalmol; 2017 Apr; 176():194-202. PubMed ID: 28130042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
